# Stroke Prevention in Sickle Cell Anemia (STOP 1)

> **NCT00000592** · PHASE3 · COMPLETED · sponsor: **Augusta University**

## Conditions studied

- Anemia, Sickle Cell
- Cerebral Embolism and Thrombosis
- Cerebrovascular Disorders
- Hematologic Diseases
- Hemoglobinopathies

## Interventions

- **PROCEDURE:** blood transfusion

## Key facts

- **NCT ID:** NCT00000592
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-07
- **Primary completion:** —
- **Final completion:** 2000-08
- **Target enrollment:** — (—)
- **Last updated:** 2015-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000592, "Stroke Prevention in Sickle Cell Anemia (STOP 1)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00000592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*